Seth Bilazarian MD has been a Clinical and Interventional Cardiologist at Pentucket Medical Associates in Massachusetts since 1993. He is board certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology, Vascular Ultrasound, Interventional Cardiology, and Vascular and Endovascular Medicine.
Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.
Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
Private practice with Dr Seth BilazarianView all posts »
Making sense of patient complianceNov 16, 2011 20:55 EST
The HOOPS and MI FREEE trials presented here at AHA 2011 delve into the enigma of patient compliance and present confounding results.
- Cutting copays for post-MI drugs helps outcomes, with no added cost to insurers
- Post-MI FREEE with Dr Niteesh Choudry
- Dr Richard Lowrie on pharmacist intervention to prevent hospitalization and death in patients with heart...